Personal information
Verified email addresses
shenchuanbin@ouc.edu.cn
Platelet, Thrombosis and Hemostasis, Integrin, Marine Drugs
Activities
Employment (3)
2022-08
to
present
|
Professor
(School of Medicine and Pharmacy)
Employment
Source:
Chuanbin Shen
2019-11
to
2022-08
|
Postdoctoral Research Fellow
(St Michael's Hospital, Keenan Research Centre for Biomedical Science)
Employment
Source:
Chuanbin Shen
2017-07
to
2019-10
|
Assistant Professor
(The Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences)
Employment
Source:
Chuanbin Shen
Education and qualifications (1)
2012-09
to
2017-07
|
PhD
(Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences)
Education
Source:
Chuanbin Shen
Funding (5)
Grant
Natural Science Foundation of Shandong Province
(Qingdao, CN)
Source:
Chuanbin Shen
Award
Unity Health Toronto
(Toronto, CA)
Source:
Chuanbin Shen
Grant
University of Toronto
(ON, ON, CA)
Source:
Chuanbin Shen
Grant
Government of Shandong Province
(Qingdao, CN)
Source:
Chuanbin Shen
Grant
National Natural Science Foundation of China
(Beijing, CN)
Source:
Chuanbin Shen
Works (31)
Biochemical and Biophysical Research Communications
2024
|
Journal article
EID:
2-s2.0-85190725879
Contributors:
MacKeigan, D.T.;
Yu, S.-Y.;
Chazot, N.;
Zhang, D.;
Khoury, C.J.;
Lei, X.;
Bhoria, P.;
Shen, C.;
Chen, P.;
Zhu, G.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
grade
Preferred source
(of
2)
Journal of Thrombosis and Haemostasis
2024
|
Journal article
EID:
2-s2.0-85203457859
Contributors:
Shen, C.;
Mackeigan, D.T.;
Shoara, A.A.;
Bhoria, P.;
Zhu, G.;
Karakas, D.;
Ma, W.;
Chen, Z.Y.;
Xu, R.;
Slavkovic, S.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
bioRxiv
2023
|
Other
EID:
2-s2.0-85185708551
Contributors:
Xue, M.;
Wang, S.;
Li, C.;
Wang, Y.;
Liu, M.;
Xiao, D.;
Yin, Q.;
Niu, L.;
Shen, C.;
Wang, J.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
Journal of Thrombosis and Haemostasis
2023-01
|
Journal article
Contributors:
Chuanbin Shen;
Daniel T. Mackeigan;
Aron A. Shoara;
Runjia Xu;
Preeti Bhoria;
Danielle Karakas;
Wenjing Ma;
Eric Cerenzia;
ZiYan Chen;
Brock Hoard
et al.
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Pharmaceuticals
2022
|
Journal article
EID:
2-s2.0-85144728703
Contributors:
Ma, W.;
Rousseau, Z.;
Slavkovic, S.;
Shen, C.;
Yousef, G.M.;
Ni, H.
Source:
Chuanbin Shen
via
Scopus - Elsevier
grade
Preferred source
(of
3)
Blood
2022
|
Journal article
EID:
2-s2.0-85140061194
Contributors:
Li, M.;
Tang, X.;
Liao, Z.;
Shen, C.;
Cheng, R.;
Fang, M.;
Wang, G.;
Li, Y.;
Tang, S.;
Xie, L.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
grade
Preferred source
(of
2)
Cellular and Molecular Life Sciences
2022
|
Journal article
EID:
2-s2.0-85128157536
Contributors:
Zhang, Z.;
Shen, C.;
Fang, M.;
Han, Y.;
Long, C.;
Liu, W.;
Yang, M.;
Liu, M.;
Zhang, D.;
Cao, Q.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
Scientific Reports
2021-12
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Archives of Toxicology
2021-11
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Frontiers in Immunology
2021-11-09
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Blood
2021-11-05
|
Journal article
Source:
Chuanbin Shen
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Toxins
2020-11
|
Journal article
|
Author
Contributors:
Chengbo Long;
Ming Liu;
Huiwen Tian;
Ya Li;
Feilong Wu;
James Mwangi;
Qiumin Lu;
Tarek Mohamed Abd El-Aziz;
Ren Lai;
Chuanbin Shen
Source:
check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source
(of
3)
Source:
Chuanbin Shen
grade
Preferred source
(of
3)
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Source:
Chuanbin Shen
grade
Preferred source
(of
3)
Cardiovascular & hematological disorders drug targets
2020-01-01
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
bioRxiv
2019
|
Other
EID:
2-s2.0-85095646232
Contributors:
Tang, X.;
Fang, M.;
Cheng, R.;
Zhang, Z.;
Wang, Y.;
Shen, C.;
Han, Y.;
Lu, Q.;
Du, Y.;
Liu, Y.
et al.
Source:
Chuanbin Shen
via
Scopus - Elsevier
Source:
Chuanbin Shen
grade
Preferred source
(of
3)
Chinese journal of natural medicines
2019-06-01
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Chinese journal of natural medicines
2017-03-01
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Chinese Journal of Natural Medicines
2016
|
Journal article
EID:
2-s2.0-84990867078
Contributors:
YAO, H.-M.;
WANG, G.;
LIU, Y.-P.;
RONG, M.-Q.;
SHEN, C.-B.;
YAN, X.-W.;
LUO, X.-D.;
LAI, R.
Source:
Chuanbin Shen
via
Scopus - Elsevier
EBioMedicine
2016-10-19
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
The international journal of biochemistry & cell biology
2014-07-12
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2014-05-27
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
The international journal of biochemistry & cell biology
2014-01-17
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)
PloS one
2013-12-30
|
Journal article
Source:
Chuanbin Shen
grade
Preferred source
(of
2)